Pacific Biosciences of California Inc. Hits New 52-Week High at $6.50 (PACB)
Shares of Pacific Biosciences of California (NASDAQ:PACB) hit a new 52-week high during mid-day trading on Wednesday, StockRatingsNetwork reports. The stock traded as high as $6.50 and last traded at $6.19, with a volume of 8,045,311 shares trading hands. The stock had previously closed at $3.46.
Pacific Biosciences of California has a 1-year low of $1.06 and a 1-year high of $4.72. The stock’s 50-day moving average is $3.76 and its 200-day moving average is $2.84. The company’s market cap is $394.8 million.
Pacific Biosciences of California (NASDAQ:PACB) last released its earnings data on Thursday, August 1st. The company reported ($0.33) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.35) by $0.02. The company had revenue of $6.04 million for the quarter, compared to the consensus estimate of $6.09 million. During the same quarter in the prior year, the company posted ($0.40) earnings per share. The company’s quarterly revenue was down 17.1% on a year-over-year basis. Analysts expect that Pacific Biosciences of California will post $-1.29 EPS for the current fiscal year.
Pacific Biosciences, Inc develops Deoxyribonucleic Acid (NASDAQ:PACB) sequencing platform.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.